Checkpoint Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights May 09, 2019
Mustang Bio Announces City of Hope Opens First-of-Its-Kind Multiple Myeloma CAR T Cell Therapy Trial Targeting CS1 Protein May 08, 2019
Checkpoint Therapeutics Announces Positive Interim Clinical Results of Anti-PD-L1 Antibody Cosibelimab May 01, 2019
St. Jude Children’s Research Hospital publishes results of Lentiviral Gene Therapy for Treatment of Infants with X-linked Severe Combined Immunodeficiency in New England Journal of Medicine Apr 17, 2019
Checkpoint Therapeutics to Present at the 2019 H.C. Wainwright Global Life Sciences Conference Apr 03, 2019